This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Psoriasis and diabetes

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Psoriasis and Diabetes

Diabetes has an increased prevalence in patients with psoriasis:

  • reported type 2 diabetes in 18.1% of patients with psoriasis and 12.3% of control (1)
  • reported that (2)
    • psoriasis is associated with diabetes independent of sex, age, smoking, and body mass index (BMI) (OR 1.53, 1.03-2.27) and that increases in BMI are associated with increasing odds of twins reporting a diagnosis of psoriasis

Genetics and Diabetes and Psoriasis Risks

  • genetic variation at IL12B, IL23R and IL23A has an influence on the risk for Psoriasis and on disease severity and type 2 diabetes mellitus

Reference:

  1. Bang CN et al. Psoriasis is associated with subsequent atrial fibrillation in hypertensive patients with left ventricular hypertrophy: the losartan intervention for endpoint study. J Hypertens. 2014;32(3):667-672
  2. Lonnberg AS et al.Heritability of psoriasis in a large twin sample.Br J Dermatol. 2013 Aug;169(2):412-6. doi: 10.1111/bjd.12375.
  3. Eirís N, Gonzalez-Lara L, Santos-Juanes J, Queiro R, Coto E, Coto-Segura P. Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus. Journal of Dermatological Science. 2014;75(3):167-172

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.